I pretty well did the same KP with SGH and was
getting a very bad feeling I was repeating the same
mistake again. That’s also why I got out. Dropped
20k but that’s better than dropping the lot I figured.
Same strategy same result...Great companies get
destroyed by people with their hand in the till who
buy “assets” at the wrong price but they’re spending
other people’s money without doing the maths in
regards to the repayments as Calvo has previously
mentioned. The one similarity that haunts me about
SGH and MYX is the “pipeline” of income from assets.
If you can’t turn the pipeline into a significant income
stream quickly enough then basic maths beats you.
If half year results are quietly going gang busters
then I’ll be kicking myself and MYX could fly. If results are
poor and Myring doesn’t hit the market quick enough then
Mayne may need to pursue a C/R for another S/R stuff up.
Can any retail holders out there afford to stump up the cash?
Banks are not forgiving for a CEO having a brain fade and
over committing company finances for products yet to hit
the market with no guarantee on time frame. The responsible
thing to do was pay down debt with cash flow to stabilise the
company’s finances/ balance sheet. Unfortunately S/R announces
just before the AGM that he’s buying in to E4/DRSP when he already
knows earnings are reducing. IMO this is financial madness/suicide.
MYX/CSL-CSL strong earnings growth where it has NO competitors.
So it can afford higher debt because it pumps out strong cash flow
and earnings growth YOY and that’s why you pay $330 a share for CSL.
CSL spends more on research per year than the value of MYX.
Great CEO’s create value over time with patience and keep the market
well informed. Impulsive desperate CEO’s don’t invest their own finances
in their own company. If S/R or any other insiders believed in the story
then why hasn’t anyone in the company bought into the story? I hope
MYX does well at the half year results but even if they do MYX has an
expensive loose cannon CEO with atrocious communication skills and
that does not bode well for the future. I don’t believe he took a lesson
from the Teva debacle and blamed the generic market for his mistake,
a mistake that if financed by debt would already have MYX in administration.
By not accepting the Teva lesson and learning from his mistake he’s likely now
created a secondary financial mistake by paying out to other companies rather
than directing those valuable finances to debt reduction.
Anyway why would he care when he’s getting paid 3 mill a year? I could retire
on one year’s worth of S/R’s wages.
Make no mistake SR is a big gambler, all or nothing. I’m sure he had to sell
a whole pile of unpaid for shares as donated by Mayne share holders on a margin
loan as called in by his financers. That says he lacks financial sophistication IMO.
I hope MYX can recover from this. It potentially has a great story to tell with the wrong
guy telling the story unfortunately. Just too many unknowns.
- Forums
- ASX - By Stock
- CEO Scott Richards - has to go
MYX
mayne pharma group limited
Add to My Watchlist
0.20%
!
$5.08

I pretty well did the same KP with SGH and wasgetting a very bad...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.08 |
Change
0.010(0.20%) |
Mkt cap ! $412.7M |
Open | High | Low | Value | Volume |
$5.13 | $5.15 | $5.08 | $445.2K | 87.01K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 810 | $5.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.15 | 2033 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 810 | 5.080 |
2 | 3150 | 5.040 |
1 | 600 | 5.030 |
3 | 3000 | 5.000 |
1 | 10000 | 4.980 |
Price($) | Vol. | No. |
---|---|---|
5.150 | 2033 | 2 |
5.180 | 2396 | 2 |
5.190 | 5000 | 1 |
5.200 | 157 | 1 |
5.210 | 5000 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online